Career history of Jens Ulrik Holst
Former positions of Jens Ulrik Holst
| Companies | Position | Start | End |
|---|---|---|---|
Arlington Capital Investors Ltd.
 Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | Investment Committee Member | 01/09/2003 | 01/02/2010 |
| Sales & Marketing | 01/09/2003 | 01/02/2010 | |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Chairman | 31/03/2010 | 31/03/2010 |
Training of Jens Ulrik Holst
| University of Mannheim | Masters Business Admin |
Statistics
International
| United Kingdom | 2 |
| Germany | 2 |
| Denmark | 2 |
Operational
| Investment Committee Member | 1 |
| Sales & Marketing | 1 |
| Masters Business Admin | 1 |
Sectoral
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | Finance |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Health Technology |
- Stock Market
- Insiders
- Jens Ulrik Holst
- Experience
